Evidence mapPaperPMID 28927191Full record

ArticleEuropean heart journal. Quality of care & clinical outcomes2017

Increasing mortality from ischaemic heart disease in China from 2004 to 2010: disproportionate rise in rural areas and elderly subjects. 438 million person-years follow-up.

Xiaofei Zhang, Arshad A Khan, Ehtesham Ul Haq, Aadil Rahim, Dayi Hu, John Attia, Christopher Oldmeadow, Xiaoyan Ma, Rongjing Ding, Andrew J Boyle

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European heart journal. Quality of care & clinical outcomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03771053 (Intravascular Ultrasound Evaluation of the Intervention Effect of Simvastatin Combined With Ezetimibe on Coronary Borderline Lesion in Patients With Stable Angina Pectoris and Diabetes Mellitus Compared With Simvastatin Alone), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03771053 naunknown statusstarted 2018, after this paper: background citation

Intravascular Ultrasound Evaluation of the Intervention Effect of Simvastatin Combined With Ezetimibe on Coronary Borderline Lesion in Patients With Stable Angina Pectoris and Diabetes Mellitus Compared With Simvastatin Alone

Ran2018Enrolled240Registered outcomes7Posted comparisons0ConditionsCoronary Heart DiseaseArmsEzetimibe with simvastatin, simvastatin
Open the trial in the graph
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Factors Associated With Hospitalization Costs of Coronary Heart Disease in Township Hospitals in Rural China.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Xiaofei ZhangDepartment of Clinical Epidemiology and Biostatistics, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Arshad A KhanDepartment of Cardiovascular Medicine, John Hunter Hospital, Locked Bag 1, HRMC, Newcastle, NSW 2310, Australia.
Ehtesham Ul HaqMiddlesboro ARH Hospital, Middlesboro, KY, USA.
Aadil RahimUniversity of Newcastle, Newcastle, NSW 2310, Australia.
Dayi HuRenmin Hospital Affiliated Peking University, Beijing, China.
John AttiaDepartment of Cardiovascular Medicine, John Hunter Hospital, Locked Bag 1, HRMC, Newcastle, NSW 2310, Australia.
Christopher OldmeadowHunter Medical Research Institute, Newcastle, NSW 2310, Australia.
Xiaoyan MaBeijing Centre for Disease Control and Prevention, Beijing, China.
Rongjing DingRenmin Hospital Affiliated Peking University, Beijing, China.
Andrew J BoyleDepartment of Cardiovascular Medicine, John Hunter Hospital, Locked Bag 1, HRMC, Newcastle, NSW 2310, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: We sought to ascertain the changes in mortality from ischaemic heart disease (IHD) from 2004 to 2010 in China as the sheer size of China's population makes disease patterns relevant globally. Methods and results: Data on IHD mortality were obtained from the Chinese Centre for Disease Control and Prevention National Disease Surveillance Point System, which includes 161 counties and a population of over 73 million-a representative sample of over 6% of the entire population of China. Both crude and World Health Organization (WHO)-standardized IHD mortality increased, in both men and women and in both urban and rural locations, during the study period, demonstrating the effect of urbanization, economic growth, and epidemiological transition on cardiovascular health. WHO-standardized IHD mortality increased for rural males by 9.2% per year (95% CI: 6.7-11.7%; P < 0.0001), and the trend was statistically significantly higher (P = 0.0001) than in urban males by 6.4% per year (95% CI: 3-10%; P = 0.02). WHO-standardized IHD mortality rate increased for rural females by 7.0% per year (95% CI: 4.6-9.4%; P < 0.0001); this was statistically significantly higher than urban females by 4.3% per year (95% CI: 1-8%; P = 0.02). The age group over 80 years showed the greatest increase in IHD mortality. Conclusions: Mortality from IHD is increasing in China, in contrast to decreasing in other countries. This is largely driven by increasing IHD mortality in rural areas and subjects over 80 years old. This needs urgent attention by public health workers and policymakers.

Indexed as

ForecastingAdultAgedAged, 80 and overAge FactorsChinaFemaleFollow-Up StudiesHumansMaleMiddle AgedMyocardial IschemiaRetrospective StudiesRural PopulationSex FactorsSurvival RateChinaIschemic heart diseaseMortality

Identifiers

PMID28927191

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.